Octreotide modified nano-formulation for cancer treatment or cancer palliative care

摘要

The present invention relates to a pharmaceutical composition for the treatment, palliative care or prevention of cancer such as medullary thyroid cancer. In particular, the present invention relates to a pharmaceutical composition for the treatment, palliative care or prevention of cancer, such as medullary thyroid cancer, comprising liposomes modified with octreotide.